biosimilar drugs

Promising new treatments for plaque psoriasisThe American College of Rheumatology annual meeting wrapped this month in San Diego. Results from long-awaited safety trials show promising new treatments.
FDA okays biosimilar for several cancers
FDA okays biosimilar for several cancersWhile FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.
Law Reauthorizes FDA Fees and Increases Access to Generics/BiosimilarsSenate passes FDARA overwhelmingly, ahead of September deadline.
Biosimilars Market Taking Off in the United StatesAfter many years of speculation, a number of biosimilar drugs are hitting the U.S. market.
Biosimilars Have Entered the Market, But Are They Safe?Biosimilars are starting to come on the market, but some have questions about their safety.
Retailers and PBMs Laud Generic/Biosimilar Savings
Retailers and PBMs Laud Generic/Biosimilar SavingsSavings from generic and biosimilar drugs are making PBMs and pharmacies, as well as patients, happy.
Pharmacists: Key Players as Biosimilars Enter the MarketPharmacists will have a central role in educating about biosimilar drugs.
Biosimilars Come  to Community Pharmacy
Biosimilars Come to Community PharmacyBiosimilars are now being dispensed from community pharmacies.
Biosimilar of Remicade Launched
Biosimilar of Remicade LaunchedRenflexis has wholesale cost 35% below Remicade.
Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.